Gillian C. Ivers-read, See Remarks at Clovis Oncology, Inc. (CLVS), sold 4,442 shares at $1.94 ($9K) on 2022-02-02, disclosed to the SEC on 2022-02-03.
Open-market sale of $9k CLVS by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.94 | 1,989 | $4K | 44.8% |
| 2 | $1.94 | 2,453 | $5K | 55.2% |
| Total | $1.94 avg | 4,442 | $9K | 100% |
| Filing → |
| CLVS | SELL | 2022-08-03 | $6K | — | Filing → |
| CLVS | SELL | 2022-06-03 | $1K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $7K | — | Filing → |